The invention relates to oral liquid for treating diseases of the liver,
gall,
stomach and intestinal canal. The oral liquid comprises the following medicaments in parts by weight: 5 to 10 parts of pilose asiabell root, 5 to 10 parts of largehead atractylodes
rhizome, 5 to 10 parts of
astragalus mongholicus, 5 to 10 parts of common yam
rhizome, 5 to 10 parts of northern
hawthorn fruit, 5 to 10 parts of malt, 5 to 10 parts of
tangerine peel, 5 to 10 parts of Chinese angelica, 5 to 10 parts of red sage root, 5 to 10 parts of
bletilla striata, 5 to 10 parts of white paeony root, 5 to 10 parts of
endothelium corneum gigeriae galli, 2 to 5 parts of liquoric root, 2 to 5 parts of Indian buead, 2 to 5 parts of finger citron, 2 to 5 parts of villous
amomum fruit, 2 to 5 parts of
officinal magnolia bark, 2 to 5 parts of Chinese eaglewood, 2 to 5 parts of
cyperus rotundus, 2 to 5 parts of medlar, 2 to 5 parts of shelled
cuttlebone, 2 to 5 parts of Chinese thorowax root, 2 to 5 parts of coastal
glehnia root, 2 to 5 parts of fragrant solomonseal
rhizome, 2 to 5 parts of Chinese magnoliavine fruit, 2 to 5 parts of shelled radish seed, 2 to 5 parts of white
hyacinth bean, 2 to 5 parts of immature bitter orange, 2 to 5 parts of costustoot, 2 to 5 parts of
coix seed and 2 to 5 parts of
lindera root. The oral liquid is clinically proven to have a definite
treatment effect on acute or chronic gastroenteritis.